The Application Tracker aims to help people keep up to date with pharmaceutical funding applications PHARMAC is considering. New applications are added as we receive them.
The Application Tracker includes all applications received since 2008, and most applications received since 2002.
Click to show/hide the remaining applications.
The following applications are not visible in the Application Tracker. All of them were received before 2008. Several have been superseded by later applications.
Paclitaxel - 100 mg injection and 6 mg/ml solution for infusion. Docetaxel - 20mg and 80 mg injection and 20 mg / 0.5 ml and 40 mg/ml solution
Clinicians
Paroxetine Mesylate
April 2004
20mg
AFT Pharmaceuticals
MabThera (Rituximab)
June 2004
Single-use vials of 100 mg / 10ml and 500 mg / 50ml solution
Clinicians
Oxaliplatin
July 2004
Vials (50 mg and 100 mg)
Sanofi-Synthelabo
Xeloda (capecitabine)
May 2005
150mg, 500mg tablets (widening access)
Roche Products (NZ) Limited
Symbicort (budesonide with efomoterol)
July 2005
Dry Powder Inhaler 100/6 mcg, 200/6 mcg
AstraZeneca
Enlive plus
January 2006
Juice Style Adult oral supplement
Abbott Nutrition
The Application Tracker tells you the key steps an application has been through, and also links you to relevant published PTAC minutes, subcommittee minutes, consultation letters, and related notifications.
You can search for applications by:
Chemical Name
Brand Name
Therapeutic Group, e.g. "Oncology and Immunosuppressants", "Special Foods"
